Skip to main content
. 2022 Jun 23;12(6):e059945. doi: 10.1136/bmjopen-2021-059945

Table 1.

Summary of study schedule

Enrolment Baseline (A0) End of intervention (A12) Follow-up (A36)
Eligibility screening X
Informed consent X
Randomisation X
Allocation X
Interventions
Centre-based CR graphic file with name bmjopen-2021-059945ilf01.jpg
Telerehabilitation graphic file with name bmjopen-2021-059945ilf02.jpg
Assessments
Demographic characteristics X
Spirometry, TTE X
Strength evaluation test X
Cardiac biomarkers (BNP, NT-proBNP, troponins, creatine kinase) X X
CPET–6MWT X X X
HRQoL X X X
HADS X X X
IPAQ X X X
FTND X X X
Cost analysis X
Training adherence X

BNP, B-type natriuretic peptide; CPET, cardiopulmonary exercise testing; CR, cardiac rehabilitation; FTND, Fagerstrom Test for Nicotine Dependence; HADS, Hospital Anxiety and Depression Scale; HRQoL, health-related quality of life; IPAQ, International Physical Activity Questionnaire; 6MWT, 6 min walk test; NT-proBNP, N-terminal pro-brain natriuretic peptide; TTE, transthoracic echocardiography.